Application of "Postoperative Ventilation Formula" in Postoperative Recovery Observed through a Multi-parameter Digital Vital Signs Monitoring System

注册号:

Registration number:

ITMCTR2025000739

最近更新日期:

Date of Last Refreshed on:

2025-04-14

注册时间:

Date of Registration:

2025-04-14

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于多参数生命体征数字化监测系统观察“术后通气方”在术后恢复中的应用

Public title:

Application of "Postoperative Ventilation Formula" in Postoperative Recovery Observed through a Multi-parameter Digital Vital Signs Monitoring System

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于多参数生命体征数字化监测系统观察“术后通气方”在术后恢复中的应用

Scientific title:

Application of "Postoperative Ventilation Formula" in Postoperative Recovery Observed through a Multi-parameter Digital Vital Signs Monitoring System

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王隽

研究负责人:

王隽

Applicant:

Wang Jun

Study leader:

Wang Jun

申请注册联系人电话:

Applicant telephone:

13914883411

研究负责人电话:

Study leader's telephone:

13914883411

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangjun_jsxz@126.com

研究负责人电子邮件:

Study leader's E-mail:

wangjun_jsxz@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

江苏省徐州市云龙区中山南路169号

研究负责人通讯地址:

江苏省徐州市云龙区中山南路169号

Applicant address:

No.169 South Zhongshan Road Yunlong District Xuzhou City Jiangsu Province

Study leader's address:

No.169 South Zhongshan Road Yunlong District Xuzhou City Jiangsu Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

徐州市中医院

Applicant's institution:

Xuzhou TCM Hospital

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2024伦审临字第(205)号

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

徐州市中医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Xuzhou Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2024/12/30 0:00:00

伦理委员会联系人:

张淑美

Contact Name of the ethic committee:

Zhang Shumei

伦理委员会联系地址:

江苏省徐州市云龙区中山南路169号

Contact Address of the ethic committee:

No.169 South Zhongshan Road Yunlong District Xuzhou City Jiangsu Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

0516-68692013

伦理委员会联系人邮箱:

Contact email of the ethic committee:

584481412@qq.com

研究实施负责(组长)单位:

徐州市中医院

Primary sponsor:

Xuzhou TCM Hospital

研究实施负责(组长)单位地址:

江苏省徐州市云龙区中山南路169号

Primary sponsor's address:

No.169 South Zhongshan Road Yunlong District Xuzhou City Jiangsu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

Country:

China

Province:

Jiangsu Province

City:

单位(医院):

徐州市中医院

具体地址:

江苏省徐州市云龙区中山南路169号

Institution
hospital:

Xuzhou TCM Hospital

Address:

No.169 South Zhongshan Road Yunlong District Xuzhou City Jiangsu Province

经费或物资来源:

第三批江苏省中医药领军人才培养项目,编号SLJ0311

Source(s) of funding:

The Third Batch of Jiangsu Province Leading Talent Training Program in Traditional Chinese Medicine Project Number SLJ0311

研究疾病:

手术患者

研究疾病代码:

Target disease:

Surgical patient

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

应用数字化、穿戴式、远程、多参数集成监测系统,监测肠功能、自主神经应激反应、血糖、睡眠、活动、阴阳昼夜节律等变化;观察胃癌患者应用“术通气方”对促进肠功能康复的疗效,并且尝试阐明术后通气方的作用机制。同时,探索围术期应用多参数生命体征数字化监测集成系统及人工智能肠鸣音监测系统的临床应用价值及意义,开辟数字医疗的新领域。

Objectives of Study:

This study employs a digitalized wearable remote and multi-parameter integrated monitoring system to track changes in intestinal function autonomic nervous stress response blood glucose sleep physical activity and yin-yang circadian rhythms. The research aims to evaluate the efficacy of the "Shu Tongqi Formula" in promoting intestinal function recovery among gastric cancer patients while also attempting to elucidate its underlying mechanisms. Additionally it explores the clinical application value and significance of a perioperative multi-parameter digital vital signs monitoring system and an AI-based bowel sound monitoring system thereby pioneering new frontiers in digital healthcare

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1. 18岁及以上 2. 围手术期患者 3. 身体状况:心肺功能正常,无严重合并症。 4. 知情同意:参与者需自愿签署知情同意书,理解研究的目的、程序、风险和潜在益处。

Inclusion criteria

1.Age: 18 years old and above. 2.Patient Population: Patients in the perioperative period. 3.Physical Condition: Normal cardiorespiratory function with no severe comorbidities. 4.Informed Consent: Participants must voluntarily sign an informed consent form understanding the purpose of the study procedures risks and potential benefits.

排除标准:

1.年龄 ≤ 18 岁 2.急诊手术 3.严重认知障碍 4.听力障碍及无法正常沟通者 5. 无法在规定佩戴部分粘贴感应器的手术患者; 6.有严重心肺功能障碍,无法耐受术后通气治疗的患者

Exclusion criteria:

1. Age ≤ 18 years old. 2. Emergency surgery. 3. Severe cognitive impairment. 4. Hearing impairment and inability to communicate normally. 5. Surgical patients who cannot wear the partial adhesive sensors as required. 6. Patients with severe cardiopulmonary dysfunction who cannot tolerate postoperative ventilation therapy.

研究实施时间:

Study execute time:

From 2025-04-15

To      2027-12-31

征募观察对象时间:

Recruiting time:

From 2025-04-15

To      2027-12-31

干预措施:

Interventions:

组别:

对照组

样本量:

500

Group:

Control group

Sample size:

干预措施:

外观与通气方相似的食品级色素制作口服液

干预措施代码:

Intervention:

Preparation of an orally administered solution using food-grade coloring agents to simulate the visual characteristics of the Tongqi Formula decoction

Intervention code:

组别:

试验组

样本量:

500

Group:

The experimental group

Sample size:

干预措施:

使用通气方

干预措施代码:

Intervention:

Using the ventilation formula

Intervention code:

样本总量 Total sample size : 1000

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

江苏省

市(区县):

Country:

China

Province:

Jiangsu Province

City:

单位(医院):

徐州市中医院

单位级别:

三甲

Institution/hospital:

Xuzhou TCM Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后住院时间

指标类型:

次要指标

Outcome:

Postoperative hospital stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血液学指标

指标类型:

次要指标

Outcome:

Hematological indicators

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率变异性

指标类型:

主要指标

Outcome:

HRV

Type:

Primary indicator

测量时间点:

测量方法:

可穿戴设备、量表

Measure time point of outcome:

Measure method:

wearable device 、scale score

指标中文名:

疼痛评分

指标类型:

次要指标

Outcome:

VAS Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

恢复质量

指标类型:

次要指标

Outcome:

Quality of Recovery (QoR)

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

scale score

指标中文名:

6分钟步行实验

指标类型:

次要指标

Outcome:

6MWT

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠质量

指标类型:

主要指标

Outcome:

sleep quality

Type:

Primary indicator

测量时间点:

测量方法:

可穿戴设备、量表

Measure time point of outcome:

Measure method:

wearable device 、scale score

指标中文名:

动态血糖监测

指标类型:

次要指标

Outcome:

Dynamic blood sugar

Type:

Secondary indicator

测量时间点:

测量方法:

可穿戴设备

Measure time point of outcome:

Measure method:

wearable device

指标中文名:

神经认知障碍

指标类型:

次要指标

Outcome:

PND

Type:

Secondary indicator

测量时间点:

测量方法:

可穿戴设备、量表

Measure time point of outcome:

Measure method:

wearable device scale score

指标中文名:

动态血压

指标类型:

次要指标

Outcome:

Dynamic blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

可穿戴设备

Measure time point of outcome:

Measure method:

wearable device

指标中文名:

肠鸣音

指标类型:

次要指标

Outcome:

intestinal gurgling sound

Type:

Secondary indicator

测量时间点:

测量方法:

可穿戴设备

Measure time point of outcome:

Measure method:

wearable device

指标中文名:

镇静评分

指标类型:

次要指标

Outcome:

Ramsay Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医院焦虑抑郁量表

指标类型:

次要指标

Outcome:

Hospital Anxiety and Depression Scale

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

scale score

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood ptysma

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 95
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究随机数字使用SPSS 26.0软件生成,将符合标准的患者随机分至实验组和对照组

Randomization Procedure (please state who generates the random number sequence and by what method):

Study random numbers were generated using SPSS 26.0 software and patients meeting the criteria were randomized to the experimental group and the control group

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

需要者向作者索取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Request it from the author

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form CRF

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above